Alzheimer's disease Archives | Be Korea-savvy
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002

ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002

NEW YORK, Friday Aug. 27 (Korea Bizwire) – ImmunoBrain Checkpoint Inc. (“IBC”) an innovative biopharmaceutical company developing potential disease-modifying immune therapies that harness the power of the immune system to help protect and repair the brain to combat neurodegenerative diseases, announced today that the National Institute on Aging (NIA) of the US National Institutes of Health (NIH) has [...]

Dementia Patients More Vulnerable to COVID-19

Dementia Patients More Vulnerable to COVID-19

SEOUL, Nov. 9 (Korea Bizwire) — A recent study has revealed that the prolonged spread of COVID-19 has left patients suffering from cognitive disorders such as dementia physically and socially more vulnerable. A research team from the Seoul National University Bundang Hospital stressed in a report that elderly people with cognitive disorders have a higher [...]

Acupuncture Proven Effective Against Alzheimer’s Disease

Acupuncture Proven Effective Against Alzheimer’s Disease

DAEJEON, Feb. 28 (Korea Bizwire) — A research team from the Korea Institute of Oriental Medicine (KIOM) revealed scientific evidence that acupuncture is effective against Alzheimer’s disease. There are currently 830,000 people over 65 years of age with dementia in South Korea, which means that at least 1 in 10 senior citizens in the country [...]

Alzheimer’s Insurance Increasingly Popular Among S. Koreans

Alzheimer’s Insurance Increasingly Popular Among S. Koreans

SEOUL, Jan. 16 (Korea Bizwire) — Insurance plans for Alzheimer’s disease have jumped in sales after the illness gained public interest in recent months. The Korea Credit Information Services reported on Wednesday that the number of applications for Alzheimer’s insurance plans reached 1.3 million early last year, up threefold since the second half of the [...]

Research Confirms Substance in Oats Fights Dementia

Research Confirms Substance in Oats Fights Dementia

SEOUL, Dec. 5 (Korea Bizwire) — South Korean researchers have discovered that oats can be effective in preventing and treating dementia. The Rural Development Administration (RDA) and Chonnam National University, in a joint experiment, fed a rat with Alzheimer’s disease an Avenanthramide C (Avn-C), substance found in oats, for two weeks. The results showed the [...]

Taconic Biosciences Launches Alzheimer’s Disease Mouse Model

Taconic Biosciences Launches Alzheimer’s Disease Mouse Model

RENSSELAER, N.Y., Nov. 4 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model.  Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes.  This combination manifests [...]

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease Based on Transcranial Photobiomodulation

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease Based on Transcranial Photobiomodulation

Toronto, Canada, Jun. 4 (Korea Bizwire) – Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study involving 228 subjects with moderate to severe cognitive impairment due to Alzheimer’s Disease. [...]